Transcatheter aortic valve replacement (TAVR) has become a well-accepted option for
treating patients with aortic stenosis at intermediate to high or prohibitive surgical risk. TAVR …

After 15 years of successive randomized, controlled trials, indications for transcatheter aortic
valve replacement (TAVR) are rapidly expanding. In the coming years, this procedure could …

Background Bicuspid aortic stenosis accounts for almost 50% of patients undergoing
surgical aortic valve replacement in the younger patients. Expanding the indication of …

Aims We sought to evaluate the outcomes of transcatheter mitral valve replacement (TMVR)
for patients with degenerated bioprostheses [valve-in-valve (ViV)], failed annuloplasty rings …

Objectives: The aim of this study was to evaluate the predictors of left ventricular outflow tract
(LVOT) obstruction after transcatheter mitral valve replacement (TMVR). Background: LVOT …

Background: Limited data exist about safety and efficacy of transcatheter aortic valve
replacement (TAVR) in patients with pure native aortic regurgitation (AR). Objectives: This …

In the 16 years since the first pioneering procedure, transcatheter aortic valve implantation
(TAVI) has come of age and become a routine strategy for aortic valve replacement …

Background: Limited data exist regarding transcatheter mitral valve replacement (TMVR) for
patients with failed mitral valve replacement and repair. Objectives: This study sought to …

Background: Few studies have evaluated the clinical outcomes of transcatheter aortic valve
replacement (TAVR) in patients with bicuspid aortic valve stenosis (AS). Particularly, limited …

Aims Transcatheter aortic valve replacement (TAVR) is now an established therapy for
intermediate-risk surgical candidates with symptomatic, severe aortic stenosis. The clinical …